Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) T.ATE


Primary Symbol: ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by CalgaryATEon Mar 05, 2021 2:29pm
247 Views
Post# 32730065

RE:RE:RE:RE:Incompetent CEO

RE:RE:RE:RE:Incompetent CEO
Layth1990 wrote:

Do you know why they will do it before phase 3. Remember my words, the deal will be high and they will load tons of shares due to ate low sp. if they do it after the ate sp will be high. Dan and wallace are highest holders at ate holding. 

not to mention the buy volume before nuance deal. Leaked news ? Or more like dan and wallce family are buying and dumped after! I have zero trust in those 2 anymore. Everything is excuted for their own good 



You might be a bit unclear as to how amalgamation will occur.  We'll dilute approximately 15% (could be a slightly higher or lower depending on negotiations) to Holdings. 

This dilution will be independent of what the share price of ATE is.  Whether the share price is $4 or $8 or whether it's $15, Holdings will get about 15% of the amalgamated company.  There's no need for anyone to manipulate the share price lower, Holdings is getting approximately 15%.

This will be offset by an increase of 15% to our royalties (profits).  Amalgamation should be a neutral event.  We keep ALL of our 85% royalties OR we get 85% of our company but get ALL of the royalties.

The lower the share price goes, does not equate to Antibe giving more shares (dilution) to Holdings.  Say you value the entire drug portfolio of Antibe to be worth $2 billion canadian.  To buy that 15% from Holdings we could give them $300 million (if we had that cash in our bank accounts), a fair deal.  We don't have that cash, we are not going to give Holdings $300 million worth of shares (currently at $4.66 would be 64 million shares and fully diluted we're at 56 million).  We are not giving Holdings 64 / (56+64) = 53% of the amalgamated company for only 15% of the royalties.

You can be upset at the share price, just realize that a lower share price does not mean we're giving away more shares in dilution.  We're pretty much giving away around 15% of the current market cap, not 15% of what the fair value of the market cap should be.

Think of it in a set number of actual shares, we'll be giving Holdings around 10 million shares (10 / (56+10) = 15%) no matter what the share price is. 

We're negotiating whether the value of the 15% royalties should really be discounted to say 12% = 7.63 million shares ( 7.63 / (56+7.63) = 12%), or whether the value of those roaylties should be say 18% = 12.3 million shares (12.3 / (56+12.3) = 18%).

<< Previous
Bullboard Posts
Next >>